BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32243611)

  • 1. B-cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement.
    Kemps PG; Cleven AHG; van Wezel T; van Eijk R; Bot FJ; Veelken H; van Balen P; Kerkhoffs JH
    Am J Hematol; 2020 Nov; 95(11):1427-1429. PubMed ID: 32243611
    [No Abstract]   [Full Text] [Related]  

  • 2. Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemia.
    Ferrari A; Ghelli Luserna Di Rora A; Domizio C; Papayannidis C; Simonetti G; Maria Hernández-Rivas J; Rondoni M; Giglio F; Abruzzese E; Imovilli A; Iacobucci I; Calistri D; Martinelli G
    Br J Haematol; 2021 Mar; 192(6):e139-e144. PubMed ID: 33314053
    [No Abstract]   [Full Text] [Related]  

  • 3. A pediatric case of
    Murphy L; Siegele B; Carstens B; Hartman L; Faulk K
    Leuk Lymphoma; 2024 Jun; 65(6):843-847. PubMed ID: 38372299
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in
    Fournier E; Inchiappa L; Delattre C; Pignon JM; Danicourt F; Bemba M; Roche-Lestienne C; Daudignon A; Decool G; Roumier C; Dumezy F; Fournier L; Grardel N; Preudhomme C; Duployez N
    Leuk Lymphoma; 2019 Jul; 60(7):1827-1830. PubMed ID: 30616415
    [No Abstract]   [Full Text] [Related]  

  • 5. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
    Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
    Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report.
    Permikin Z; Popov A; Verzhbitskaya T; Riger T; Plekhanova O; Makarova O; Froňková E; Trka J; Meyer C; Marschalek R; Tsaur G; Fechina L
    Leuk Res; 2022 Jan; 112():106758. PubMed ID: 34864370
    [No Abstract]   [Full Text] [Related]  

  • 7. Romidepsin enhances the efficacy of cytarabine
    Cheung LC; Cruickshank MN; Hughes AM; Singh S; Chua GA; Ford J; Ferrari E; Oommen J; Malinge S; Lock RB; Kees UR; Kotecha RS
    Haematologica; 2019 Jul; 104(7):e300-e303. PubMed ID: 30679330
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of constitutive activation of FMS-related tyrosine kinase-3 and
    Fedders H; Alsadeq A; Schmäh J; Vogiatzi F; Zimmermann M; Möricke A; Lenk L; Stadt UZ; Horstmann MA; Pieters R; Schrappe M; Stanulla M; Cario G; Schewe DM
    Haematologica; 2017 Nov; 102(11):e438-e442. PubMed ID: 28838992
    [No Abstract]   [Full Text] [Related]  

  • 9. Extramedullary relapse of
    Aldoss I; Song JY
    Blood; 2018 May; 131(22):2507. PubMed ID: 29853461
    [No Abstract]   [Full Text] [Related]  

  • 10. Bilateral ovarian B-lineage lymphoblastic lymphoma with MLL gene rearrangement: a novel case in infancy.
    Larish AM; Dolan M; Casey T; Perkins JL
    J Pediatr Hematol Oncol; 2015 May; 37(4):e215-7. PubMed ID: 25493458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
    Chijimatsu I; Imanaka Y; Tomizawa D; Eguchi M; Nishimura S; Karakawa S; Miki M; Hamamoto K; Fujita N
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28675638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia.
    Sarkar S; Rav E; Stitzlein L; Gibson A; McCall D; Nunez C; Roth M; Ragoonanan D; Connors J; Herzog CE; Cuglievan B; Garcia MB
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30964. PubMed ID: 38514796
    [No Abstract]   [Full Text] [Related]  

  • 13. Relapsed infant MLL-rearranged acute lymphoblastic leukemia with additional genetic alterations.
    Ishida H; Kanamitsu K; Washio K; Muraoka M; Sakakibara K; Matsubara T; Kanzaki H; Shimada A
    Pediatr Blood Cancer; 2016 Nov; 63(11):2059-60. PubMed ID: 27322816
    [No Abstract]   [Full Text] [Related]  

  • 14. Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)-rearranged infant acute lymphoblastic leukaemia.
    Emerenciano M; Barbosa Tda C; de Almeida Lopes B; Meyer C; Marschalek R; Pombo-de-Oliveira MS
    Br J Haematol; 2015 Jul; 170(2):268-71. PubMed ID: 25613690
    [No Abstract]   [Full Text] [Related]  

  • 15. Trametinib inhibits
    Kerstjens M; Pinhancos SS; Castro PG; Schneider P; Wander P; Pieters R; Stam RW
    Haematologica; 2018 Apr; 103(4):e147-e150. PubMed ID: 29419436
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLL-Rearranged Acute Lymphoblastic Leukemia.
    El Chaer F; Keng M; Ballen KK
    Curr Hematol Malig Rep; 2020 Apr; 15(2):83-89. PubMed ID: 32350732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Cutaneous Diffuse Large B-Cell Lymphoma With KMT2A-MLLT3: An Infantile Case Study.
    Hiroki H; Yoshimi A; Kato K; Yanai T; Koike K
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):657-658. PubMed ID: 31205223
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1".
    da Fonseca Bastos ACS; da Silva Rezende AC; Ferreira LB; Blunck CB; Pombo-de-Oliveira MS; Emerenciano M; Gimba ERP
    Leuk Res; 2020 Apr; 91():106316. PubMed ID: 32114371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.